Literature DB >> 4521474

Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.

J F Halazun, H R Wagner, J F Gaeta, L F Sinks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4521474     DOI： 10.1002/1097-0142(197402)33:2<545::aid-cncr2820330233>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Daunorubicin and the heart.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

2.  Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.

Authors:  M A Mir
Journal:  Br Heart J       Date:  1978-07

3.  Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.

Authors:  C Paul; M Björkholm; I Christenson; L Engstedt; G Gahrton; R Hast; G Holm; A Killander; B Lantz; D Lockner; B Lönnqvist; H Mellstedt; J Palmblad; C Peterson; B Simonsson; A M Stalfelt; A M Udén; B Wadman; G Oberg
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Kawasaki-like disease in early course of acute monocytic leukaemia.

Authors:  H Akita; S Matsuoka; Y Takahashi; T Watanabe; Y Takaue; Y Kuroda
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 5.  Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.

Authors: 
Journal:  Br J Haematol       Date:  2009-02-22       Impact factor: 6.998

6.  Anthracycline cardiomyopathy.

Authors:  N L Kobrinsky; N K Ramsay; W Krivit
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.